Investing Profile

Kou Qin

InvestorVC
Managing Director of Investment at Eisai Innovation Inc
Boston, Massachusetts
Photo of Kou Qin, Managing Director at Eisai Innovation, Inc.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
898 CONNECTIONS
Cornell University Network
390 CONNECTIONS
Tired Girls Incorporated Network
17 CONNECTIONS
Tired Girls Incorporated Network
17 CONNECTIONS
Eisai Innovation, Inc. Managing Director
$100K - $5.0M
$1.5M
Seed Investor Kernal BiologicsPresent
Seed Investor Orange HealthPresent
Investor Orange HealthPresent
Investor Kernal BiologicsPresent
Investor 炎明生物 Pyrotech TherapeuticsPresent
Principal of Investment Eisai Innovation IncPresent
Investor TraveraPresent
Venture Capitalist Eisai InnovationPresent
Board Observer Tired Girls IncorporatedPresent
Board Observer Ophidion BioPresent
Board Observer RiboX TherapeuticsPresent
Board Observer Casma TherapeuticsPresent
Managing Director of Investment Eisai Innovation IncPresent
Investor Tune TherapeuticsPresent
Board Observer Hyku BiosciencesPresent
Investor IambicPresent
Investor eGenesisPresent
Board Observer ProTgen Inc.Present
Board Observer Vivacta BiotechnologyPresent
Board Observer Aikelian BiotechnologyPresent
Senior Director of Investment Eisai Innovation IncPresent
Board Member Tired Girls IncorporatedPresent
CEO and Co-founder SkinomePresent
Partner TTM CapitalPresent
Huazhong University of Science and Technology BE Biomedical Engineering
Cornell University PhD, Pharmacology, Neuroscience Pharmacology, Neuroscience
Medical College of Georgia at Augusta University PhD Pharmacology, Neuroscience
Harvard University Master of Science (SM) Biostatistics, Bioinformatics
Sign in with Google →
Sign in with Google →